Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

Conditions: Prostate Cancer Interventions: Drug: Docetaxel; Drug: ADT; Drug: Abiraterone Sponsors: Northwestern University; National Cancer Institute (NCI) Not yet recruiting

https://clinicaltrials.gov/study/NCT06060587

Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials